Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s ...

Employers are projecting a median 10% increase in healthcare costs for 2026, driven largely by high claims and specialty drug ...

You don’t have to practice in Florida for this law to matter. Patient interest in regenerative care is growing rapidly, and ...

The Department of Justice has reached a proposed settlement with UnitedHealth Group and Amedisys regarding UnitedHealth’s ...

The Trump administration is directing the Department of Health and Human Services to identify about 26 “critical medicines.” ...

A judge recently blocked an Arkansas law that would have banned PBMs from owning and operating pharmacies in the state.

Some large health systems are experimenting with selling their internal capabilities — such as IT support, revenue cycle management and call center operations — to smaller hospitals as a new ...

Pfizer’s inclacumab did not beat a placebo in a Phase 3 test in sickle cell disease. The trial failure comes nearly a year after Pfizer voluntarily withdrew Oxbryta from the market after tests ...